This inventor holds 1 USPTO granted patent. Top assignee: Alembic Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Trushar Rajnikant Shah: Innovator in Pharmaceutical Chemistry
Introduction
Trushar Rajnikant Shah is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes for drug preparation. His work exemplifies the intersection of science and practical application in the pharmaceutical industry.
Latest Patents
Trushar Rajnikant Shah holds a patent for a process titled "Process for the preparation of indolone derivative." This patent involves the preparation of 4-[2-(Di-n-propylamino)ethyl]-2,3-dihydro-1H-indol-2-one and its pharmaceutically acceptable salts and solvates. The process utilizes new intermediates of compounds, which include various halogen atoms and sulfonyloxy groups, showcasing his expertise in complex chemical synthesis.
Career Highlights
Trushar is currently employed at Alembic Limited, a prominent pharmaceutical company known for its commitment to innovation and quality in drug development. His role at Alembic Limited allows him to apply his inventive skills in a collaborative environment, contributing to the advancement of pharmaceutical solutions.
Collaborations
Throughout his career, Trushar has worked alongside talented colleagues such as Rohit Ravikant Soni and Hitarth Harshendu Acharya. These collaborations have fostered a creative atmosphere that encourages the exchange of ideas and the development of groundbreaking pharmaceutical technologies.
Conclusion
Trushar Rajnikant Shah's contributions to pharmaceutical chemistry through his innovative patent and collaborative efforts at Alembic Limited highlight his role as a key figure in the industry. His work continues to impact the field positively, paving the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
